DF Dent & Co’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-75,000
| Closed | -$10.9K | – | 273 |
|
|
2025
Q1 | $10.9K | Buy |
+75,000
| New | +$10.9K | ﹤0.01% | 259 |
|
|
2024
Q4 | – | Sell |
-75,000
| Closed | -$9K | – | 271 |
|
|
2024
Q3 | $9K | Buy |
+75,000
| New | +$9K | ﹤0.01% | 261 |
|
|
2024
Q2 | – | Sell |
-75,000
| Closed | -$30K | – | 271 |
|
|
2024
Q1 | $30K | Buy |
+75,000
| New | +$30K | ﹤0.01% | 263 |
|
|
2023
Q4 | – | Sell |
-75,000
| Closed | -$39.4K | – | 275 |
|
|
2023
Q3 | $39.4K | Hold |
75,000
| – | – | ﹤0.01% | 253 |
|
|
2023
Q2 | $14.3K | Buy |
+75,000
| New | +$14.3K | ﹤0.01% | 255 |
|
|
2022
Q2 | – | Sell |
-75,000
| Closed | -$94K | – | 261 |
|
|
2022
Q1 | $94K | Buy |
+75,000
| New | +$94K | ﹤0.01% | 256 |
|
|
2014
Q3 | – | Sell |
-22,500
| Closed | -$111K | – | 171 |
|
|
2014
Q2 | $111K | Buy |
+22,500
| New | +$111K | ﹤0.01% | 166 |
|
|
2014
Q1 | – | Sell |
-15,000
| Closed | -$91K | – | 236 |
|
|
2013
Q4 | $91K | Hold |
15,000
| – | – | ﹤0.01% | 252 |
|
|
2013
Q3 | $99K | Hold |
15,000
| – | – | ﹤0.01% | 159 |
|
|
2013
Q2 | $76K | Buy |
+15,000
| New | +$76K | ﹤0.01% | 155 |
|